ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,537Medicare Part D Prescriptions Filled, Including Refills

Rank: 17 out of 68

$457K Total Retail Price of All Prescriptions

Rank: 23 out of 68

273 Patients Receiving at Least One Drug in Part D
83%Patients 65 Years and Older
72% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Pennsylvania
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 273 patients filled at least one prescription for a schedule two drug, compared to an average of 11%.

Schedule Three
Controlled Substances

10% of this provider’s 273 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

1% of this provider’s 9,214 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$43 was the average price of a prescription from this provider, compared to $52 among peers.

Prescriptions per Patient

39 is the average number of prescriptions (including refills) per patient, compared to an average of 29.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Pennsylvania
SIMVASTATIN 495 431 1 1
LISINOPRIL 345 292 2 4
METOPROLOL TARTRATE 334 314 3 6
LEVOTHYROXINE SODIUM 334 331 3 2
HYDROCHLOROTHIAZIDE 326 277 5 11
FUROSEMIDE 281 264 6 3
WARFARIN SODIUM 263 243 7 8
OMEPRAZOLE 253 234 8 5
POTASSIUM CHLORIDE 246 220 9 18
AMLODIPINE BESYLATE 211 169 10 7
CITALOPRAM HBR 189 177 11 9
NAMENDA 188 188 12 16
DONEPEZIL HCL 169 169 13 10
METFORMIN HCL 169 120 13 14
HYDROCODONE-ACETAMINOPHEN 160 143 S3 15 17
SERTRALINE HCL 154 126 16 20
GABAPENTIN 153 135 17 12
POLYETHYLENE GLYCOL 3350 144 141 18 22
PAROXETINE HCL 137 102 19 93
DIOVAN 127 102 20 42
LABETALOL HCL 120 108 21 159
ALENDRONATE SODIUM 112 107 22 26
MIRTAZAPINE 111 111 23 15
RANITIDINE HCL 111 74 23 34
ATENOLOL 104 95 25 21
TRAZODONE HCL 98 79 26 32
TRIAMCINOLONE ACETONIDE 96 75 27 85
GLIPIZIDE 93 67 28 54
CLOPIDOGREL 92 89 29 31
DIGOXIN 82 74 30 45
ISOSORBIDE MONONITRATE ER 82 80 30 35
CARVEDILOL 81 78 32 27
PHENYTOIN SODIUM EXTENDED 75 57 33 118
PRAVASTATIN SODIUM 74 51 34 29
TRAMADOL HCL 72 57 35 23
BUMETANIDE 71 71 36 58
SPIRIVA 70 68 37 60
RISPERIDONE 67 67 38 25
METOPROLOL SUCCINATE 66 61 39 19
ADVAIR DISKUS 63 55 40 41
ALLOPURINOL 62 59 41 46
PREDNISONE 62 54 41 47
CEPHALEXIN 62 60 41 115
DILTIAZEM 24HR CD 61 49 44 86
CELEBREX 59 56 45 112
BUSPIRONE HCL 54 22 46 98
OXYBUTYNIN CHLORIDE 54 42 46 89
PLAVIX 54 52 46 48
DILTIAZEM 24HR ER 52 43 49 133
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 9, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.